
Americans have more healthcare than ever, pay proportionally less out of pocket, and lead the world in cancer survival. And they are angrier about healthcare than almost any other issue. The problem isn't insurance companies. It's what 70 years of third-party payment taught us to expect.
Read the story →America's healthcare system — covering 92% of the population, costing patients just 11 cents of every dollar spent — was never designed. It was built through a series of accidents, incentives, and unexpected consequences, starting with a wartime wage control in 1942.
Read the story →A nurse with a smartphone. A single retinal photograph. An algorithm that reads it in seconds and returns a diagnosis with the accuracy of a specialist who trained for a decade. This is not a pilot program. It is running...
Read the story →Global life expectancy has risen from 48 years in 1950 to 73 years today. Every year of that gain represents a solved problem — a disease defeated, a technology deployed, a system that reached someone it couldn't reach before.
Read the story →Child mortality has been cut by more than half since 1990. It is the greatest humanitarian achievement of the modern era. You've barely heard about it.
Read the story →Your biological age and birth year diverge. 5 biomarkers longevity doctors track — and what you can actually do about the results.
Read the story →GLP-1 receptor agonists were approved for diabetes. Then the weight loss data came in. Not 5-8% reductions — 15-22% of body weight, sustained. The fastest-growing drug class in history.
Read the story →Rapamycin extends lifespan in every mammal tested. Senolytics clear the cells that drive aging. The science is real, the drugs exist, and the medical establishment has barely noticed.
Read the story →A 12,112-person study at ASCO 2026 shows GLP-1 drugs may reduce cancer metastasis. The drug that rewrote the rules on diabetes and obesity just opened a third chapter.
Read the story →